Mariner’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History

Mariner’s Portfolio OPNT Stock Details OPNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10,550	Closed	-$214K	–	2926
2022 Q4	$214K	Sell	10,550 -3,000	-22%	-$46K	﹤0.01%	2300
2022 Q3	$146K	Buy	+13,550	New	+$154K	﹤0.01%	2118
2022 Q2	–	Sell	-13,550	Closed	-$290K	–	1477
2022 Q1	$290K	Buy	+13,550	New	+$359K	﹤0.01%	1289

Mariner's OPNT Position: Q1 2023 in Review

Mariner sold out of Opiant Pharmaceuticals, Inc. Common Stock (OPNT) in Q1 2023, closing a stake of 10,550 shares — an estimated $214K sold.

Mariner first reported a position in OPNT in Q1 2022 and held it in 3 quarters. The position peaked at $290K in Q1 2022. 0 funds tracked by Wall St. Rank hold OPNT as of Q1 2023.

Mariner reported no remaining Opiant Pharmaceuticals, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Mariner sold 10,550 Opiant Pharmaceuticals, Inc. Common Stock shares in Q1 2023, an estimated $214K.
Mariner first reported a position in Opiant Pharmaceuticals, Inc. Common Stock in Q1 2022 and held it in 3 quarters.
Mariner's Opiant Pharmaceuticals, Inc. Common Stock position peaked at $290K in Q1 2022.
0 funds tracked by Wall St. Rank held Opiant Pharmaceuticals, Inc. Common Stock as of Q1 2023.

Based on Mariner's 13F filing for Q1 2023, filed 15 May 2023.